DI BELLA METHOD
>
DOCUMENTATION INDEX > MDB - Documents
PET imaging of somatostatin receptors using [68GA]DOTA-D-Phe1-Tyr3-octreotide: first results in patients with meningiomas.
(30/05/2003)
Detail
Functional imaging as an aid to decision-making in metastatic paraganglioma.
(30/05/2003)
Detail
Emerging indications for octreotide therapy, Part 1.
(30/05/2003)
Detail
Indium-111-DOTA-lanreotide: biodistribution, safety and radiation absorbed dose in tumor patients.
(30/05/2003)
Detail
Targeting of cytotoxic somatostatin analog AN-238 to somatostatin receptor subtypes 5 and/or 3 in experimental pancreatic cancers.
(30/05/2003)
Detail
Neuroendocrine tumor targeting: study of novel gallium-labeled somatostatin radiopeptides in a rat pancreatic tumor model.
(30/05/2003)
Detail
Detection of primary breast cancer presenting as metastatic carcinoma of unknown primary origin by 111In-pentetreotide scan.
(30/05/2003)
Detail
Detection and measurement of in vitro gene transfer by gamma camera imaging.
(30/05/2003)
Detail
Immunocytochemical detection of somatostatin receptors sst1, sst2A, sst2B, and sst3 in paraffin-embedded breast cancer tissue using subtype-specific antibodies.
(30/05/2003)
Detail
Immunohistochemical detection of somatostatin receptor types 1-5 in medullary carcinoma of the thyroid.
(30/05/2003)
Detail
Immunohistochemical detection of somatostatin receptors in human ovarian tumors.
(30/05/2003)
Detail
Immunohistochemical detection of somatostatin receptor subtypes sst1 and sst2A in human somatostatin receptor positive tumors.
(30/05/2003)
Detail
Intraoperative tumour detection using 111In-DTPA-D-Phe1-octreotide and a scintillation detector.
(30/05/2003)
Detail
Intraoperative detection of lung cancer by octreotide labeled to Indium-111.
(30/05/2003)
Detail
Apoptosis-induction and phosphorylation state in human pancreatic carcinoma xenografts following octreotide treatment.
(30/05/2003)
Detail